259 related articles for article (PubMed ID: 31220376)
21. Corneal Complications Related to Dupilumab Use.
Tauber J; Ritterband DC; Kang JJ
Eye Contact Lens; 2024 Jun; 50(6):270-273. PubMed ID: 38661491
[TBL] [Abstract][Full Text] [Related]
22. Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up.
Bohner A; Topham C; Strunck J; Haynes D; Brazil M; Clements J; Simpson E; Chamberlain W
Cornea; 2021 May; 40(5):584-589. PubMed ID: 32826648
[TBL] [Abstract][Full Text] [Related]
23. Dupilumab-associated ocular manifestations: A review of clinical presentations and management.
Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL
Surv Ophthalmol; 2022; 67(5):1419-1442. PubMed ID: 35181280
[TBL] [Abstract][Full Text] [Related]
24. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
Gupta AK; Love RP; Abramovits W; Vincent KD
Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
[No Abstract] [Full Text] [Related]
25. Development of Sézary syndrome following the administration of dupilumab.
Tran J; Morris L; Vu A; Duvic M
Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621690
[TBL] [Abstract][Full Text] [Related]
26. Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Am Acad Dermatol; 2020 May; 82(5):1247-1249. PubMed ID: 31884090
[No Abstract] [Full Text] [Related]
27. Hair regrowth and dissemination of molluscum contagiosum: two unexpected effects with dupilumab.
Sevray M; Dupré D; Misery L; Abasq-Thomas C
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e296-e298. PubMed ID: 30875133
[No Abstract] [Full Text] [Related]
28. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study.
Schneeweiss MC; Kim SC; Wyss R; Schneeweiss S; Merola JF
J Am Acad Dermatol; 2021 Feb; 84(2):300-311. PubMed ID: 33038471
[TBL] [Abstract][Full Text] [Related]
29. Improvement of dupilumab-associated conjunctivitis after switching to upadacitinib in a patient with atopic dermatitis.
Hayama K; Fujita H
Dermatol Ther; 2022 Jul; 35(7):e15575. PubMed ID: 35536445
[No Abstract] [Full Text] [Related]
30. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
31. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials.
Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M
Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707
[No Abstract] [Full Text] [Related]
32. Analysis of cytokines in tear fluid from atopic dermatitis patients with dupilumab-associated ocular adverse events.
Vuillemey L; Febvay C; Puzenat E; Bellanger AP; Chague C; Puyraveau M; Delbosc B; Gauthier AS; Aubin F
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e195-e197. PubMed ID: 34626023
[No Abstract] [Full Text] [Related]
33. Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
Treister AD; Kraff-Cooper C; Lio PA
JAMA Dermatol; 2018 Oct; 154(10):1208-1211. PubMed ID: 30167653
[TBL] [Abstract][Full Text] [Related]
34. Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.
Uchida H; Kamata M; Mizukawa I; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
Br J Dermatol; 2019 Nov; 181(5):1083-1085. PubMed ID: 31127860
[No Abstract] [Full Text] [Related]
35. Two cases of psoriasiform dermatitis arising during dupilumab therapy and successfully treated with delgocitinib ointment.
Kurihara K; Fujiyama T; Tokura Y; Honda T
Eur J Dermatol; 2021 Oct; 31(5):658-660. PubMed ID: 34704949
[No Abstract] [Full Text] [Related]
36. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.
Armario-Hita JC; Pereyra-Rodriguez J; Silvestre JF; Ruiz-Villaverde R; Valero A; Izu-Belloso R; Jáuregui-Presa I; Curto-Barredo L; Figueras-Nart I; Herranz-Pinto P; Herraez-Herrera L; Ortiz-de-Frutos FJ; Martinez-Pilar L; Sastre J; Serra-Baldrich E
Br J Dermatol; 2019 Nov; 181(5):1072-1074. PubMed ID: 31021399
[No Abstract] [Full Text] [Related]
37. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
[TBL] [Abstract][Full Text] [Related]
38. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.
Thyssen JP; de Bruin-Weller MS; Paller AS; Leshem YA; Vestergaard C; Deleuran M; Drucker AM; Foelster-Holst R; Traidl-Hoffmann C; Eyerich K; Taieb A; Su JC; Bieber T; Cork MJ; Eichenfield LF; Guttman-Yassky E; Wollenberg A
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1224-1231. PubMed ID: 31056788
[TBL] [Abstract][Full Text] [Related]
39. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
Yamane MLM; Belsito DV; Glass LRD
Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
[TBL] [Abstract][Full Text] [Related]
40. Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis.
Ivert LU; Wahlgren CF; Ivert L; Lundqvist M; Bradley M
Acta Derm Venereol; 2019 Apr; 99(4):375-378. PubMed ID: 30653240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
